Company Overview and News

 
Marsden Point oil refinery hits near-record profit

2018-09-18 nzherald.co.nz
The Marsden Point oil refinery processed a near-record 7.62 million barrels of oil during the past two months.
ZNZ ZNRGF ZEL

 
NZ shares surge to record as market reopens

2018-08-29 nzherald.co.nz
New Zealand shares surged to a record as the market reopened after yesterday's platform failure. Synlait Milk and A2 Milk Co led the gains.
CEN FBU WBC FCREY ZNRGF WEBNF WBK FRCEF ZEL COENY COENF SKT ZNZ GNE SYKWF WBC FBU CEN SNZ SKKTY GNE GEL SML

 
NZ shares hit record; Synlait, a2 gain while Sky TV, Z Energy drop

2018-08-27 nzherald.co.nz
New Zealand shares hit a record, led higher by Synlait Milk and a2 Milk Co while Sky Network Television continued Friday's decline.
MQBKY AIA MHI ZNRGF MXRHY MCQEF ACKDF ZEL AUKNY SKT ZNZ SYKWF AIA SKKTY SKLUY SKL MQG SML MXRHF

 
Z Energy to take major stake in Flick Electric

2018-08-26 radionz.co.nz
Fuel retailer Z Energy is diversifying with a move to take a major stake in electricity retailer, Flick Electric.
ZNZ ZNRGF ZEL

 
Z Energy's $46m power play for Flick Electric

2018-08-26 nzherald.co.nz
Z Energy will pay $46 million for a 70 per cent shareholding in Flick Electric, the retail electricity supplier that was the first in the country to offer customers access to the spot price of electricity.
ZNZ ANZLY AIR ZNRGF ANZFF ANZFY ZEL AIZ

 
Māori leaders pitch to Māori landowners - let us pay to plant trees and we will share the carbon credit profits

2018-08-16 nzherald.co.nz
A carbon-trading business seeking to unlock millions of dollars from communal Māori land is launching today in a scheme which will provide the Government's Billion Trees plan a massive boost.
ZNZ MTSI ZNRGF ZEL

 
Freightways, Sky TV lead NZ shares gain

2018-07-31 nzherald.co.nz
New Zealand shares gained, led higher by Freightways and Sky Network Television as the market remains quiet ahead of earnings season.
CEN ZNRGF KMD COENF SKT ZNZ GNE SYKWF SKC CEN SKKTY FGHRY KMD GEL KTHDY EBOSY FLT ZEL EBO COENY KWIPF EBOSF EVO GNE GTK EBO

1
NZ shares up, Pushpay rebounds from selling while Synlait, Sky TV gain

2018-07-27 nzherald.co.nz - 1
The S&P/NZX50 Index rose 63.68 points, or 0.7 per cent, to 8,996.16. Within the index, 25 stocks rose, 17 fell and eight were unchanged. Turnover was $87.5 million.
SKT ZNZ SYKWF THL ZNRGF SKKTY ZEL FTRRF SML

1
Revealed: Entrepreneur of the Year finalists

2018-07-26 nzherald.co.nz - 1
Twenty-two businesspeople from 17 businesses and industries are vying for the 2018 EY Entrepreneur of the Year.
ZNZ AIA AIA ZNRGF 3905 ACKDF ZEL AUKNY

1
MARKET WRAP: NZ shares rise as Pushpay, Kathmandu fall

2018-07-24 nbr.co.nz - 1
Hamilton Hindin Greene investment adviser Tom McBride says Smiths City’s announcement resembles The Warehouse in 2014.
ZNZ ZNRGF ZEL

1
NZ companies, councils, not 'walking talk' on climate risk

2018-07-22 nzherald.co.nz - 1
New Zealand hasn't been "walking the talk" on climate risk, finds a sweeping new analysis of hundreds of annual reports and statements.
ZNZ ANZLY AIR ZNRGF ANZFF ANZFY ZEL AIZ

 
NZ shares down, led lower by A2 and Z Energy

2018-07-19 nzherald.co.nz
New Zealand shares dropped, led lower by A2 Milk Co and Z Energy, while Trustpower and Summerset gained.
KTHDY ZNZ PPSHY ZNRGF ZEL KMD SML KMD

 
NZ shares drop on Z Energy downgrade

2018-07-18 nzherald.co.nz
New Zealand shares fell, led by Z Energy following an earnings downgrade, with Ryman Healthcare and NZX also declining.
KTHDY PGC ZNZ RHCGF RYHTY ZNRGF GTK RYM ZEL KMD KMD

 
MARKET WRAP: NZ shares fall as Z Energy revises guidance

2018-07-18 nbr.co.nz
Fat Prophets head of research Greg Smith says leading the declines on the New Zealand market was Z Energy.
ZNZ ZNRGF ZEL SML HLG

 
Z Energy shares take a hit after earnings downgrade

2018-07-18 nbr.co.nz
Z Energy shares have taken a small tumble after the company revised its earnings guidance for the 2019 financial year to $420-455 million, down from the previous range of $450-485m.
ZNZ ZNRGF ZEL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to NZX:ZEL / Z Energy Limited on message board site Silicon Investor.

Pretzels Pretzels Pretzels The Pretzel Scandal - Unmoderated The Pretzel Scandal - Unmoderated The Pretzel Scandal - Unmoderated
Wenzel Downhole Tools Ltd (WZL) - was Master Downhole Wenzel Downhole Tools Ltd (WZL) - was Master Downhole Wenzel Downhole Tools Ltd (WZL) - was Master Downhole Gizelleu0027s Dartboard Gizelleu0027s Dartboard Gizelleu0027s Dartboard